HEADER HORMONE 24-NOV-16 5MHD TITLE BIOSYNTHETIC ENGINEERED A22S-B3K-B31R HUMAN INSULIN MONOMER STRUCTURE TITLE 2 IN WATER/ACETONITRILE SOLUTIONS. COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CHAIN A; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: INSULIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: CHAIN B; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: INS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: INS; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HUMAN INSULIN, WATER/ACETONITRILE SOLUTION, MUTANT, HORMONE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR W.BOCIAN,L.KOZERSKI,E.BEDNAREK,J.SITKOWSKI REVDAT 2 08-MAY-19 5MHD 1 REMARK REVDAT 1 09-AUG-17 5MHD 0 JRNL AUTH E.BEDNAREK,J.SITKOWSKI,W.BOCIAN,P.BOROWICZ,G.PUCIENNICZAK, JRNL AUTH 2 D.STADNIK,W.SURMACZ-CHWEDORUK,B.JAWORSKA,L.KOZERSKI JRNL TITL STRUCTURE AND PHARMACEUTICAL FORMULATION DEVELOPMENT OF A JRNL TITL 2 NEW LONG-ACTING RECOMBINANT HUMAN INSULIN ANALOG STUDIED BY JRNL TITL 3 NMR AND MS. JRNL REF J PHARM BIOMED ANAL V. 135 126 2017 JRNL REFN ISSN 1873-264X JRNL PMID 28024260 JRNL DOI 10.1016/J.JPBA.2016.12.005 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DYANA, AMBER 14 REMARK 3 AUTHORS : GUNTERT P. (DYANA), CASE, DARDEN, CHEATHAM III, REMARK 3 SIMMERLING, WANG, DUKE, LUO, ... AND KOLLMAN REMARK 3 (AMBER) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DGSA-DISTANCE GEOMETRY SIMULATED REMARK 3 ANNEALING REMARK 4 REMARK 4 5MHD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-NOV-16. REMARK 100 THE DEPOSITION ID IS D_1200002457. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 2.5 REMARK 210 IONIC STRENGTH : 1 REMARK 210 PRESSURE : AMBIENT PA REMARK 210 SAMPLE CONTENTS : 2.5 MM NONE INSULIN, 73 % NONE REMARK 210 H2O, 27 % 2H CD3CN, H2O / CD3CN; REMARK 210 2.5 MM NONE INSULIN, 73 % 2H D2O, REMARK 210 27 % 2H CD3CN, D2O / CD3CN REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY; REMARK 210 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : UNIFORM NMR SYSTEM REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : 20 STRUCTURES FOR LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 4060 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 1 TYR A 19 CB - CG - CD2 ANGL. DEV. = -4.0 DEGREES REMARK 500 1 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 2 TYR A 19 CB - CG - CD2 ANGL. DEV. = -4.1 DEGREES REMARK 500 2 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 3 TYR A 19 CB - CG - CD2 ANGL. DEV. = -5.0 DEGREES REMARK 500 3 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 4 TYR A 19 CB - CG - CD2 ANGL. DEV. = -4.3 DEGREES REMARK 500 4 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 5 TYR A 19 CB - CG - CD1 ANGL. DEV. = -4.5 DEGREES REMARK 500 5 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 6 TYR A 19 CB - CG - CD2 ANGL. DEV. = -4.3 DEGREES REMARK 500 6 ARG B 22 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 7 TYR A 19 CB - CG - CD2 ANGL. DEV. = -3.8 DEGREES REMARK 500 7 ARG B 22 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 8 TYR A 19 CB - CG - CD1 ANGL. DEV. = -3.8 DEGREES REMARK 500 9 TYR A 19 CB - CG - CD2 ANGL. DEV. = -3.9 DEGREES REMARK 500 9 ARG B 22 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 10 TYR A 19 CB - CG - CD2 ANGL. DEV. = -3.8 DEGREES REMARK 500 10 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 11 TYR A 19 CB - CG - CD1 ANGL. DEV. = -4.1 DEGREES REMARK 500 11 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 12 TYR A 19 CB - CG - CD1 ANGL. DEV. = -4.1 DEGREES REMARK 500 13 TYR A 19 CB - CG - CD2 ANGL. DEV. = -4.0 DEGREES REMARK 500 13 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 14 TYR A 19 CB - CG - CD2 ANGL. DEV. = -4.7 DEGREES REMARK 500 14 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 15 TYR A 19 CB - CG - CD2 ANGL. DEV. = -4.0 DEGREES REMARK 500 15 ARG B 22 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 16 TYR A 19 CB - CG - CD1 ANGL. DEV. = -4.0 DEGREES REMARK 500 17 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 18 TYR A 19 CB - CG - CD1 ANGL. DEV. = -4.4 DEGREES REMARK 500 18 ARG B 22 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 19 CYS A 20 CA - CB - SG ANGL. DEV. = 8.2 DEGREES REMARK 500 19 ARG B 31 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 20 TYR A 19 CB - CG - CD1 ANGL. DEV. = -5.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 9 -133.37 -114.27 REMARK 500 1 GLU B 21 14.43 51.34 REMARK 500 2 SER A 9 -132.72 -115.78 REMARK 500 2 GLU B 21 16.29 59.31 REMARK 500 3 SER A 9 -122.07 -111.75 REMARK 500 3 GLU B 21 -12.49 -151.78 REMARK 500 3 TYR B 26 18.70 48.65 REMARK 500 3 THR B 30 -22.14 66.55 REMARK 500 4 SER A 9 -148.95 -113.07 REMARK 500 4 ASN A 21 37.29 -92.48 REMARK 500 4 GLU B 21 -12.06 -152.81 REMARK 500 4 TYR B 26 43.28 -84.45 REMARK 500 4 LYS B 29 -2.05 -145.10 REMARK 500 5 TYR B 26 12.54 -151.09 REMARK 500 6 GLU B 21 14.12 57.78 REMARK 500 7 SER A 9 -136.83 -120.89 REMARK 500 7 THR B 27 54.74 36.14 REMARK 500 8 SER A 9 -129.96 -115.21 REMARK 500 8 ASN A 21 36.41 -84.58 REMARK 500 9 SER A 9 -156.66 -128.16 REMARK 500 11 SER A 9 -141.69 -105.71 REMARK 500 11 GLU B 21 -9.88 -151.76 REMARK 500 12 GLU B 21 19.27 51.60 REMARK 500 13 ASN A 21 37.64 -89.46 REMARK 500 13 GLU B 21 -8.94 -151.44 REMARK 500 13 THR B 27 51.80 37.16 REMARK 500 13 LYS B 29 -52.83 -146.79 REMARK 500 14 ASN A 21 46.69 -86.59 REMARK 500 14 TYR B 26 12.08 -150.76 REMARK 500 14 PRO B 28 76.70 -68.56 REMARK 500 15 GLU B 21 -13.52 -151.95 REMARK 500 15 THR B 27 55.18 38.59 REMARK 500 15 THR B 30 12.41 56.57 REMARK 500 17 THR B 27 52.99 39.68 REMARK 500 18 GLU B 21 16.60 59.94 REMARK 500 20 SER A 9 -140.88 -114.58 REMARK 500 20 GLU B 21 9.58 58.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 TYR A 19 0.20 SIDE CHAIN REMARK 500 2 TYR A 19 0.20 SIDE CHAIN REMARK 500 3 TYR A 19 0.21 SIDE CHAIN REMARK 500 4 TYR A 19 0.19 SIDE CHAIN REMARK 500 5 TYR A 19 0.22 SIDE CHAIN REMARK 500 6 TYR A 19 0.18 SIDE CHAIN REMARK 500 7 TYR A 19 0.20 SIDE CHAIN REMARK 500 7 ARG B 22 0.08 SIDE CHAIN REMARK 500 8 TYR A 19 0.19 SIDE CHAIN REMARK 500 9 TYR A 19 0.21 SIDE CHAIN REMARK 500 10 TYR A 19 0.20 SIDE CHAIN REMARK 500 11 TYR A 19 0.20 SIDE CHAIN REMARK 500 12 TYR A 19 0.21 SIDE CHAIN REMARK 500 13 TYR A 19 0.21 SIDE CHAIN REMARK 500 14 TYR A 19 0.23 SIDE CHAIN REMARK 500 15 TYR A 19 0.23 SIDE CHAIN REMARK 500 16 TYR A 19 0.21 SIDE CHAIN REMARK 500 17 TYR A 19 0.21 SIDE CHAIN REMARK 500 18 TYR A 19 0.19 SIDE CHAIN REMARK 500 19 TYR A 19 0.18 SIDE CHAIN REMARK 500 20 TYR A 19 0.23 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34070 RELATED DB: BMRB REMARK 900 BIOSYNTHETIC ENGINEERED A22S-B3K-B31R HUMAN INSULIN MONOMER REMARK 900 STRUCTURE IN WATER/ACETONITRILE SOLUTIONS. DBREF 5MHD A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 5MHD B 1 31 UNP P01308 INS_HUMAN 25 55 SEQADV 5MHD SER A 22 UNP P01308 EXPRESSION TAG SEQADV 5MHD LYS B 3 UNP P01308 ASN 27 CONFLICT SEQRES 1 A 22 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 22 TYR GLN LEU GLU ASN TYR CYS ASN SER SEQRES 1 B 31 PHE VAL LYS GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 31 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 31 THR PRO LYS THR ARG HELIX 1 AA1 ILE A 2 CYS A 7 1 6 HELIX 2 AA2 SER A 12 GLU A 17 1 6 HELIX 3 AA3 GLY B 8 CYS B 19 1 12 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.03 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.03 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.01 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1